Timing of Prophylactic Antibiotics for Cesarean Sections
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00330278 |
Recruitment Status :
Completed
First Posted : May 26, 2006
Last Update Posted : September 27, 2007
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Endometritis Wound Infection | Drug: Cefazolin | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Enrollment : | 350 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double |
Primary Purpose: | Prevention |
Official Title: | A Randomized, Double-Blind, Placebo Controlled Trial of Cefazolin Given Either 30 Minutes Prior to Cesarean Section or at Cord Clamping |
Study Start Date : | January 2003 |
Actual Study Completion Date : | January 2006 |

- Combined infectious morbidity - endometritis + wound infection
- Neonatal sepsis
- Allergic reactions

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Pregnant 24-43 weeks gestation > 18 years old Requiring cesarean section -
Exclusion Criteria:
Receiving antibiotics < 18 years old Allergy to cefazolin
-

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00330278
United States, South Carolina | |
Medical University of South Carolina | |
Charleston, South Carolina, United States, 29425 |
Principal Investigator: | Scott A Sullivan, MD | Medical University of South Carolina |
ClinicalTrials.gov Identifier: | NCT00330278 |
Other Study ID Numbers: |
HR # 11120 |
First Posted: | May 26, 2006 Key Record Dates |
Last Update Posted: | September 27, 2007 |
Last Verified: | January 2006 |
Cesarean section Antibiotic prophylaxis Cefazolin |
Wound Infection Endometritis Infection Pelvic Inflammatory Disease Adnexal Diseases |
Uterine Diseases Cefazolin Anti-Bacterial Agents Anti-Infective Agents |